Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bioresour Technol ; 124: 90-4, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22989638

RESUMEN

The aim of the present work was to improve the C:O ratio in biomass by preserving the lignin macrostructure of lignocellulosic feed. The intention of liquid phase pyrolysis is to liquefy biomass and prepare biomass for further upgrading steps like hydrogenation and deoxygenation. Pyrolysis was carried out in a non-aqueous liquid phase heat carrier. The process was carried out in a semi-batch reaction vessel under isothermal conditions at T=350°C, supported by a quench to stop reactions instantaneously in order to observe formation of solid intermediates. This pyrolysis system enables the observation of liquid and solid product formation. Transformation of biomass into biochar was analyzed by infrared spectroscopy and elemental analysis. Stable lignin structure throughout the whole transformation was confirmed. It was shown that the lignin frame in wood remains without substantial loss, while the major amount of carbohydrates is pyrolyzed during liquid phase pyrolysis at T=350°C.


Asunto(s)
Calor , Biomasa , Lignina/metabolismo
2.
Pathologe ; 31 Suppl 2: 292-5, 2010 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-20652266

RESUMEN

Intratumoral heterogeneity of HER2 protein expression and HER2 gene amplification can negatively affect determination of HER2 status in a subset of invasive breast carcinomas. The frequency and clinical significance of HER2 genetic heterogeneity are unknown due to the lack of uniform criteria for diagnosis. Recent ASCO/CAP guidelines (2009) define HER2 genetic heterogeneity as the presence of between 5% and 50% of tumor cells with a HER2/CEP17 ratio >2.2. We describe a tool (a customized Excel spreadsheet) for easy and reproducible diagnosis of HER2 genetic heterogeneity according to ASCO/CAP criteria. Our tool may be useful for routine HER2 diagnostics and for studies to analyse the hitherto unknown predictive significance of HER2 genetic heterogeneity.


Asunto(s)
Biomarcadores de Tumor/genética , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Heterogeneidad Genética , Receptor ErbB-2/genética , Cromosomas Humanos Par 17/genética , Femenino , Amplificación de Genes/genética , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Hibridación Fluorescente in Situ/métodos , Invasividad Neoplásica/genética , Invasividad Neoplásica/patología , Guías de Práctica Clínica como Asunto , Pronóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...